A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer
Empreu sempre aquest identificador per citar o enllaçar aquest ítem
http://hdl.handle.net/10045/77775
Títol: | A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer |
---|---|
Autors: | Jover-Esplá, Ana Gabriela | Palazón Bru, Antonio | Folgado-de la Rosa, David M. | Juan Herrero, Joaquín de | Gil Guillén, Vicente |
Grups d'investigació o GITE: | Biotecnología |
Centre, Departament o Servei: | Universidad de Alicante. Departamento de Biotecnología |
Paraules clau: | Glottis | Laryngeal neoplasms | Mobile applications | Models | Statistical | Mortality |
Àrees de coneixement: | Biología Celular |
Data de publicació: | de juliol-2018 |
Editor: | John Wiley & Sons |
Citació bibliogràfica: | European Journal of Cancer Care. 2018, 27(4): e12860. doi:10.1111/ecc.12860 |
Resum: | Only one prognostic model for laryngeal cancer has been published, but it has not been properly validated and is only applicable to patients treated with radiotherapy. Consequently, we constructed, internally validated and implemented in an App (Android), a predictive model of 5‐year mortality in patients with glottic cancer in a cohort study of 189 patients with glottic cancer in 2004–2016 in Spain. The main variable was time‐to‐death. Secondary variables were age, gender, TNM, stage, smoking, alcohol consumption, histology and treatment. A scoring system to predict mortality at 5 years was constructed, validated internally by bootstrapping and then integrated into an Android app. In all, 70 patients died (37.0%, 76 deaths per 1,000 patient‐years). The predictive model had the following prognostic factors: larger tumour size, greater degree of lymph node metastasis, higher stage, smoking and alcohol consumption. The internal validation of the model through bootstrapping was satisfactory. In conclusion, a points system to predict mortality at 5 years in patients with glottic cancer has been constructed, internally validated and integrated into an Android application. External validation is suggested to make available a quick and simple tool to establish the prognosis for these patients. |
URI: | http://hdl.handle.net/10045/77775 |
ISSN: | 0961-5423 (Print) | 1365-2354 (Online) |
DOI: | 10.1111/ecc.12860 |
Idioma: | eng |
Tipus: | info:eu-repo/semantics/article |
Drets: | © 2018 John Wiley & Sons Ltd |
Revisió científica: | si |
Versió de l'editor: | https://doi.org/10.1111/ecc.12860 |
Apareix a la col·lecció: | INV - GIDBT - Artículos de Revistas |
Arxius per aquest ítem:
Arxiu | Descripció | Tamany | Format | |
---|---|---|---|---|
2018_Jover-Espla_etal_EurJCancerCare_final.pdf | Versión final (acceso restringido) | 458,95 kB | Adobe PDF | Obrir Sol·licitar una còpia |
Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.